Pancreatic Cancer Research

ResearcherUniversitätsmedizin RostockActive in the last 2 years

Sander Bekeschus

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8773-8862; OpenAlex author ID A5053623492. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 12

  1. Protocol for generating a 3D hydrogel-based tumor resection model in vitro using pancreatic cancer cells. Last author DOI 10.1016/j.xpro.2026.104416↗
  2. The Chamber Gap Assay Is a Simple and Sensitive In Vitro Method for Studying Pancreatic Cancer-Induced Macrophage Recruitment and Morphological Alteration. Co-author DOI 10.3390/biology15030240↗
  3. RAW264.7 Macrophages as a Polarization Model in the Context of Pancreatic Cancer and Chemokine Release. Last author DOI 10.3390/biology14040320↗
  4. CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice. Co-author DOI 10.3390/biomedicines11061517↗
  5. Pancreatic Cancer Cells Undergo Immunogenic Cell Death upon Exposure to Gas Plasma-Oxidized Ringers Lactate. Last author DOI 10.3390/cancers15010319↗
  6. Murine Macrophages Modulate Their Inflammatory Profile in Response to Gas Plasma-Inactivated Pancreatic Cancer Cells. Last author DOI 10.3390/cancers13112525↗
  7. Gas Plasma-Conditioned Ringer's Lactate Enhances the Cytotoxic Activity of Cisplatin and Gemcitabine in Pancreatic Cancer In Vitro and In Ovo. Last author DOI 10.3390/cancers12010123↗
  8. RAW 264.7 Macrophage Polarization by Pancreatic Cancer Cells - A Model for Studying Tumour-promoting Macrophages. Last author DOI 10.21873/anticanres.13416↗
  9. Risk Assessment of kINPen Plasma Treatment of Four Human Pancreatic Cancer Cell Lines with Respect to Metastasis. Co-author DOI 10.3390/cancers11091237↗
  10. Cold Physical Plasma-Treated Buffered Saline Solution as Effective Agent Against Pancreatic Cancer Cells. Co-author DOI 10.2174/1871520618666180507130243↗
  11. Cold Physical Plasma Selectively Elicits Apoptosis in Murine Pancreatic Cancer Cells In Vitro and In Ovo. Last author DOI 10.21873/anticanres.12901↗
  12. Non-thermal plasma-treated solution demonstrates antitumor activity against pancreatic cancer cells in vitro and in vivo. First author DOI 10.1038/s41598-017-08560-3↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lea Miebach · 5 shared papers, 2023–2026 · strength 1.47
  2. Aydar Khabipov · 5 shared papers, 2019–2026 · strength 1.05
  3. Stephan Kersting · 4 shared papers, 2021–2026 · strength 0.93
  4. Maik Lenz · 3 shared papers, 2023–2026 · strength 0.80
  5. Kim Rouven Liedtke · 6 shared papers, 2017–2021 · strength 0.61
  6. Lars-Ivo Partecke · 5 shared papers, 2018–2021 · strength 0.54
  7. André Käding · 5 shared papers, 2017–2021 · strength 0.48
  8. Lars Ivo Partecke · 3 shared papers, 2017–2023 · strength 0.33
  9. Wolfram von Bernstorff · 2 shared papers, 2017–2023 · strength 0.24
  10. Angela Privat‐Maldonado · 1 shared paper, 2019 · strength 0.08
  11. Annemie Bogaerts · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.